Exosome Technologies Market:
Introduction
According to the report, the global exosome technologies market was valued over US$ 31 Mn
in 2020 and
is projected to expand at a CAGR of ~24% from 2021 to 2031.
Exosomes are extracellular vehicles secreted from human body cells. Exosomes
play a crucial role in the intercellular transportation of protein and RNA.
Recently, exosomes have been tested for numerous therapeutic applications,
including biomarkers, drug delivery systems, and therapies for diseases such as
cancer, renal neurological, and cardiovascular diseases. Increase in awareness
about exosome technologies & government initiatives are the key factors
projected to drive the global exosome technologies market during the forecast
period. North America held major share of the global exosome technologies
market in 2020, owing to high incidence rate of chronic
diseases such as cancer and cardiovascular diseases, technological
advancements, and rise in acceptance of these technologies in the region.
Moreover, strategies adopted by key players are anticipated to augment the
market in the U.S. The exosome technologies market in the Asia Pacific is
expected to expand at a CAGR of 8.5% from 2021 to 2031 due
to government initiatives to improve healthcare infrastructure.
Request
a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=65840
Rise in Prevalence of Chronic
Diseases to Drive Global Market
The prevalence of cardiovascular diseases has increased across the
globe due to change in dietary habits. According to Centers for Disease Control
and Prevention statistics, heart diseases account for nearly 655,000 deaths
in the U.S. each year. Cancer is also a leading cause of death globally, caused
due to lifestyle-related factors such as alcohol consumption, tobacco
consumption, and some food-related factors. According to the World Health
Organization statistics, in 2018, an estimated 18.1 million
new cases of cancer and 9.6 million deaths were reported across the
globe. Aging is considered a major risk factor for neurodegenerative diseases.
Therefore, a surge in the geriatric population contributes to the increase in
the number of patients with various brain diseases. Moreover, changing
environmental conditions and human behavior affect the spread and impact of
infectious diseases. Therefore, rise in prevalence of various chronic diseases
is likely to boost the global exosomes technologies market during the forecast
period.
Request for Analysis of COVID19
Impact on Exosome Technologies Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=65840
Loaded Cargo Held Major Share of
Exosome Technologies Market
In terms of exosome type, the global exosome technologies market
has been bifurcated into loaded cargo and non-cargo. The loaded cargo segment
dominated the market in 2020. Exosomes carry various types of proteins,
lipids, and nucleic acids (mRNA and non-coding RNA). Exosomes with therapeutic
cargo help to cross the natural membranous barriers, such as the blood-brain
barrier (BBB), to achieve better therapeutic efficiency of brain diseases.
This, in turn, is projected to drive the segment.
MSCs Dominated Exosome
Technologies Market
Based on cell source, the global exosome technologies market has
been classified into HEK293, MSCs, platelets, erythrocytes, natural killer
cells (NKs), and others. The MSCs segment dominated the global exosome
technologies market in 2020, and the trend is anticipated to continue during
the forecast period. MSCs have immunomodulatory properties to regulate various
cells involved in immune responses and exhibit potent cell therapeutics for
various diseases for the last few decades. This factor is expected to propel
the segment.
Request
For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=65840
Diagnostics to Lead Global Market
In terms of indication, the global exosome technologies market has
been categorized into therapeutics and diagnostics. The diagnostics segment
held major share of the global exosome technologies market in 2020.
The segment’s dominance can be attributed to reimbursement, availability, and
approval of new exosome diagnostics products.
Healthcare Providers to be Key End
Users
Based on end user, the global exosome technologies market has been
divided into healthcare providers, pharmaceutical & biotechnology
companies, and others. The healthcare providers segment held a major share of
the global exosome technologies market in 2020. The
segment’s dominance can be attributed to the increase in the geriatric
population suffering from various diseases.
Buy now Exosome Technologies
Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=65840<ype=S
North America to Dominate Global
Market
In terms of region, the global exosome technologies market has
been divided into North America, Europe, Latin America, Asia Pacific, and
Middle East & Africa. North America is projected to account for prominent
share of the global exosome technologies market during the forecast period.
Extensive in-house manufacturing & research capacity, large customer base,
and a well-established healthcare infrastructure are the major factors driving
the market in North America. The market in Europe is anticipated to expand at a
high CAGR in the near future, owing to strategies adopted by key players and
grants of patent for exosomes in the region. The exosome technologies market in
Asia Pacific is projected to grow at a rapid pace in the near future. This can
be attributed to government initiatives to improve healthcare infrastructure.
For instance, the Government of Japan and a team of industry players announced
a collaboration leveraging exosomes to improve cancer diagnosis and its
treatment.
Growth Strategies of Key Players
Key players operating in the global exosome technologies market
are Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine
Therapeutics, Ciloa SAS, Codiak BioSciences, Creative Biolabs, Danaher
Corporation (Beckman Coulter), Direct Biologics, ExoCan Healthcare Technologies
Pvt. Ltd., ExoCoBio, ExonanoRNA LLC, Exopharm, Exosome Diagnostics, Inc.
(BIO-TECHNE CORPORATION), Fujifilm, ILIAS Biologics, Inc., Illumina, Inc.,
Invitrix Therapeutics, XOStem, Inc., VivaZome Therapeutics Pty Ltd., Thermo
Fisher Scientific, Inc., Organicell, OmniSpirant Ltd., and Novadip Biosciences.
These companies engage in research & development to develop novel products
in order to expand product offerings and customer base. For instance, in June
2020, Sarepta Therapeutics, Inc. entered into a collaboration with Codiak
BioSciences to research and develop exosome-based therapeutics for rare
diseases.
More
Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/rising-number-of-cancer-related-deaths-and-the-need-for-efficient-treatment-options-to-tackle-the-swelling-fatality-rate-will-aid-in-boosting-the-growth-of-the-radiation-therapy-market-says-tmr-301304147.html
https://www.prnewswire.com/news-releases/increased-number-of-patients-with-hereditary-antithrombin-deficiency-boosts-sales-in-antithrombin-market-tmr-301309026.html
https://www.prnewswire.com/news-releases/developers-of-robotic-technologies-lean-on-safety-and-accuracy-to-boost-patient-outcomes-in-surgical-robots-market-global-valuation-to-touch-us-13-1-bn-by-2022-tmr-301312625.html
About Us
Transparency Market Research is a
next-generation market intelligence provider, offering fact-based solutions to
business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for
businesses to grow, evolve, and mature. Our real-time data collection methods
along with ability to track more than one million high growth niche products
are aligned with your aims. The detailed and proprietary statistical models
used by our analysts offer insights for making right decision in the shortest
span of time. For organizations that require specific but comprehensive
information we offer customized solutions through adhoc reports. These requests
are delivered with the perfect combination of right sense of fact-oriented
problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for
clients-specific problems with right methodology of research is the key to help
enterprises reach right decision.”
Contact
Transparency
Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel:
+1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
